Market Research Report
North America Peripheral Vascular Devices Market Forecast 2021-2028
|North America Peripheral Vascular Devices Market Forecast 2021-2028|
Published: March 1, 2021
Content info: 132 Pages
Delivery time: 2-3 business days
The North America peripheral vascular devices market is expected to grow at a CAGR of 10.86% during the forecast period, 2021-2028. The changing lifestyle habits like excessive alcohol consumption and unhealthy dietary habits, obesity, smoking, and lack of physical activity, make the region susceptible to peripheral artery disease, thereby driving the market growth.
The United States and Canada are assessed for the North America peripheral vascular devices market growth evaluation. In Canada, there is an increasing awareness about peripheral vascular disease (PVD). According to the National Institute of Health, the prevalence rate in terms of atherosclerosis are high, i.e., 38% for cholesterol, 48% for smoking history, 15% for diabetes, and 43% for blood pressure. Whereas, the prevalence of PVD in the country is 12-15%. The country ranks fourth in medical device exports as per the International Trade Administration. This indicates the market stability regarding peripheral vascular devices. The government is also taking initiatives to make the population aware of PVD, and thereby minimize the mortality of PVD.
Furthermore, peripheral artery disease is under-treated and unrecognized in comparison to other cardiovascular diseases. Several PAD awareness programs are implemented to increase the level of knowledge and risk factors. Moreover, the geriatric population (aged 65 and above) is set to increase considerably by 2030. Such factors are expected to drive market growth in Canada.
Some of the prominent companies in the market include, Teleflex Medical, Boston Scientific Corporation, Terumo Interventional Systems Inc, Endologix, Becton, Dickinson and Company, etc.